Home / REGENERON PHARMACEUTICALS, INC. (REGN)

REGENERON PHARMACEUTICALS, INC. (REGN) Technical Analysis

Updated: 2026-06-05 13:55 UTC · Last close: 637.52 (+1.40%) · Resistance: 689.28
REGENERON PHARMACEUTICALS, INC. (REGN) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬆️ Resistance
689.28
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 0
Watch Level
744.44
RSI(14)
41.5
📊 Technical Summary
At a glance
Trend
Vulnerable
Momentum
Neutral
Range
47% of 52W range
Key Zone
Resistance 689.28
REGENERON PHARMACEUTICALS, INC. (REGN) finished the session at 637.52 (+1.40%). Broader technical structure remains under pressure. Momentum remains weak (-10.10%); 52W position: 46% of range; and Volatility: ATR14 3.23%. RSI(14) stands around 41.5, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop.
🎯
Key levels: On the upside, 689.28 is the nearest resistance area.
•
A cleaner push through that zone would improve continuation potential.
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Long-term structure remains supportive
📈 Growth: Moderate 💰 Profit: Positive 💵 Cash: Pressured 🛡 Balance: Manageable
• Quarterly revenue is still growing, but the pace is cooling from earlier highs.
• Quarterly profitability is positive, though margins are not especially strong.
💵 Revenue
3.61B
📈 Net Income
727.20M
🧮 EPS (Basic)
6.99
🏢 Company
REGENERON PHARMACEUTICALS, INC.
🏷 Sector
Healthcare
🧩 Industry
Biotech
Compare with related stocks
Same sector and industry ideas for deeper research
Amgen (AMGN) technical analysisAxsome Therapeutics (AXSM) technical analysisBeam Therapeutics (BEAM) technical analysisCrispr Therapeutics Ag (CRSP) technical analysisAmicus Therapeutics (FOLD) technical analysisImmunitybio (IBRX) technical analysisAbbVie (ABBV) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
REGN Chart